Top Markets
Coin of the day
PRF Technologies Ltd. PRF Technologies Ltd.

PRF Technologies Ltd.

PRFX
Rang in aandelen #40770
PRF Technologies Ltd. operates as a specialized pharmaceutical company,... PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Aandeelprijs
$1.04
Marktkapitalisatie
$83.35K
Verandering (1 dag)
0.49%
Verandering (1 jaar)
-85.72%
Land
IL
Handel PRF Technologies Ltd. (PRFX)

Categorie

Dividendrendementgeschiedenis voor PRF Technologies Ltd. (PRFX)
Het dividendrendement (TTM) van PRF Technologies Ltd. (aandelsymbool: PRFX) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van PRF Technologies Ltd. (PRFX) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten